Synopsis
Fibrin plays a central role in wound healing. It has a hemostatic effect by forming a temporary wound closure and assists in neovascularization and fibroblast prolifera- tion. It therefore makes the repair of injured or severed parts of the human body by simple glueing possible, a notion that men have dreamed of since ancient times. The first modern attempts in this direction, using clotting substances derived from human blood to achieve hemostasis, were reported by Bergel (in 1909), Grey (in 1915), and Harvey (in 1916), who used fibrin powder or fibrin patches to control bleeding from parenchymatous organs. Two decades later Young and Medawar (1940) and Cronkite (1944) used blood plasma or fibrin solutions, adding thrombin to seal nerve anastomoses and to fix skin grafts in humans. Due to the poor adhesive strength of the fibrinogen the results were unsatisfactory. In 1972 a new era in fibrin sealing was initiated by Matras. By using highly concentrated fibrinogen in combination with factor XIII (fibrin-stabilizing factor) and by delaying fibrinolysis with a fibrinolysis inhibitor (aprotinin), a method was developed which after satisfactory results in animals, soon began to be applied in humans.
"synopsis" may belong to another edition of this title.
Product Description
This volume presents the experimental and clinical assessment of fibrin sealing in endoscopy. It is based on a Symposium held in Salzburg, December 1988 and updates information availabe since the first symposium held in Vienna, 1985. Results show that, since fibrin sealing came into clinical use 13 years ago, it has become an accepted tool in many fields of surgery and increased postoperative safety. The indications and limitations of new methods are discussed here, specifically, fibrin sealing for the endoscopic closure of broncho-pleural and gastro-intestinal fistulae, for the endoscopic hemostasis of bleeding gastro-duodenal ulcers, and for the occlusion of the pancreatic duct.
"About this title" may belong to another edition of this title.
Other Popular Editions of the Same Title
Search results for Progress in Fibrin Sealing
Stock Image
Progress in Fibrin Sealing
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. In. Seller Inventory # ria9783540507970_new
Buy New
£ 96.88
£ 11.98 shipping
Ships from United Kingdom to U.S.A.
Ships from United Kingdom to U.S.A.
Quantity: Over 20 available
Seller Image
Progress in Fibrin Sealing
Published by
Springer Berlin Heidelberg, Springer Berlin Heidelberg Apr 1989, 1989
ISBN 10: 3540507973
ISBN 13: 9783540507970
New
Taschenbuch
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Fibrin plays a central role in wound healing. It has a hemostatic effect by forming a temporary wound closure and assists in neovascularization and fibroblast prolifera tion. It therefore makes the repair of injured or severed parts of the human body by simple glueing possible, a notion that men have dreamed of since ancient times. The first modern attempts in this direction, using clotting substances derived from human blood to achieve hemostasis, were reported by Bergel (in 1909), Grey (in 1915), and Harvey (in 1916), who used fibrin powder or fibrin patches to control bleeding from parenchymatous organs. Two decades later Young and Medawar (1940) and Cronkite (1944) used blood plasma or fibrin solutions, adding thrombin to seal nerve anastomoses and to fix skin grafts in humans. Due to the poor adhesive strength of the fibrinogen the results were unsatisfactory. In 1972 a new era in fibrin sealing was initiated by Matras. By using highly concentrated fibrinogen in combination with factor XIII (fibrin-stabilizing factor) and by delaying fibrinolysis with a fibrinolysis inhibitor (aprotinin), a method was developed which after satisfactory results in animals, soon began to be applied in humans. 168 pp. Englisch. Seller Inventory # 9783540507970
Seller Image
Progress in Fibrin Sealing
Published by
Springer Berlin Heidelberg, 1989
ISBN 10: 3540507973
ISBN 13: 9783540507970
New
Softcover
Seller: moluna, Greven, Germany
Seller rating 5 out of 5 stars
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Principles of Fibrin Sealing.- Fibrin Sealant: Efficacy, Quality, and Safety.- Fistula Therapy.- Endoscopic Sealing of Infected Bronchus Stump Fistulae with Fibrin Following Lung Resections.- A New Biological Implant for the Closure of Bronchopleural Fistul. Seller Inventory # 4891723
Buy New
£ 80.83
£ 41.66 shipping
Ships from Germany to U.S.A.
Ships from Germany to U.S.A.
Quantity: Over 20 available
Stock Image
Progress in Fibrin Sealing
Seller: Revaluation Books, Exeter, United Kingdom
Seller rating 5 out of 5 stars
Paperback. Condition: Brand New. 1st edition. 168 pages. 9.61x6.69x0.40 inches. In Stock. Seller Inventory # x-3540507973
Seller Image
Progress in Fibrin Sealing
Print on DemandSeller: preigu, Osnabrück, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. Progress in Fibrin Sealing | Hans-Werner Waclawiczek | Taschenbuch | xiv | Englisch | 1989 | Springer Gabler | EAN 9783540507970 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. Seller Inventory # 106332064
Seller Image
Progress in Fibrin Sealing
Published by
Springer Berlin Heidelberg, Springer Gabler Apr 1989, 1989
ISBN 10: 3540507973
ISBN 13: 9783540507970
New
Taschenbuch
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Fibrin plays a central role in wound healing. It has a hemostatic effect by forming a temporary wound closure and assists in neovascularization and fibroblast prolifera tion. It therefore makes the repair of injured or severed parts of the human body by simple glueing possible, a notion that men have dreamed of since ancient times. The first modern attempts in this direction, using clotting substances derived from human blood to achieve hemostasis, were reported by Bergel (in 1909), Grey (in 1915), and Harvey (in 1916), who used fibrin powder or fibrin patches to control bleeding from parenchymatous organs. Two decades later Young and Medawar (1940) and Cronkite (1944) used blood plasma or fibrin solutions, adding thrombin to seal nerve anastomoses and to fix skin grafts in humans. Due to the poor adhesive strength of the fibrinogen the results were unsatisfactory. In 1972 a new era in fibrin sealing was initiated by Matras. By using highly concentrated fibrinogen in combination with factor XIII (fibrin-stabilizing factor) and by delaying fibrinolysis with a fibrinolysis inhibitor (aprotinin), a method was developed which after satisfactory results in animals, soon began to be applied in humans.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 168 pp. Englisch. Seller Inventory # 9783540507970
Seller Image
Progress in Fibrin Sealing
Published by
Springer Berlin Heidelberg, Springer Gabler, 1989
ISBN 10: 3540507973
ISBN 13: 9783540507970
New
Taschenbuch
Seller: AHA-BUCH GmbH, Einbeck, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Fibrin plays a central role in wound healing. It has a hemostatic effect by forming a temporary wound closure and assists in neovascularization and fibroblast prolifera tion. It therefore makes the repair of injured or severed parts of the human body by simple glueing possible, a notion that men have dreamed of since ancient times. The first modern attempts in this direction, using clotting substances derived from human blood to achieve hemostasis, were reported by Bergel (in 1909), Grey (in 1915), and Harvey (in 1916), who used fibrin powder or fibrin patches to control bleeding from parenchymatous organs. Two decades later Young and Medawar (1940) and Cronkite (1944) used blood plasma or fibrin solutions, adding thrombin to seal nerve anastomoses and to fix skin grafts in humans. Due to the poor adhesive strength of the fibrinogen the results were unsatisfactory. In 1972 a new era in fibrin sealing was initiated by Matras. By using highly concentrated fibrinogen in combination with factor XIII (fibrin-stabilizing factor) and by delaying fibrinolysis with a fibrinolysis inhibitor (aprotinin), a method was developed which after satisfactory results in animals, soon began to be applied in humans. Seller Inventory # 9783540507970
Stock Image
Progress in Fibrin Sealing
Seller: BUCHSERVICE / ANTIQUARIAT Lars Lutzer, Wahlstedt, Germany
Seller rating 5 out of 5 stars
Condition: gut. Progress in Fibrin Sealing In deutscher Sprache. pages. Seller Inventory # BN292388